In early modern Japan, upper status groups coveted pills and powders made of exotic foreign ingredients such as mummy and rhinoceros horn. By the early twentieth century, over-the-counter-patent medicines, and, more alarmingly, morphine, had become mass commodities, fueling debates over opiates in Japan’s expanding imperial territories. The fall of the empire and the occupation of Japan by the United States created conditions favorable for heroin use, followed, in time, by glue sniffing and psychedelic mushroom ingestion. By illuminating the neglected history of drugs, this volume highlights both the transnational embeddedness and national peculiarities of the “politics of consumption” in Japan. Contributors are: Anna Andreeva, Oleg Benesch, William G. Clarence-Smith, Hung Bin Hsu, John Jennings, Miriam Kingsberg Kadia, William Marotti, Kōji Ozaki, Jonas Rüegg, Jesús Solís, Christopher W.A. Szpilman, Judith Vitale, and Timothy Yang.

This book examines the history of drugs in Japan over four centuries, from the early modern period through the present day, showing how the definition, consumption, and regulation of substances both shaped and reflected trends in Japanese society.

The International Military Tribunal for the Far East (IMTFE) found Japan guilty of deliberately promoting drug abuse as a weapon to further its imperialistic aims in Asia. This study provides the historical context behind the IMTFE's findings from the annexation of Taiwan in 1895 to the end of World War II. Given the extent to which drug use permeated the politics, economy, and culture of Asia, it was inevitable that Japan's rise as an imperial power would lead to contact with, and increasing involvement in, the opium and narcotics trade. This study argues that the nature of that involvement should be understood not simply in terms of a conspiracy to drug the people of Asia into submission, but rather as indicative of the general twists and turns of Japanese imperialism. Thus, opium and narcotics emerge not so much as a weapon of, but rather as a metaphor for, Japanese imperialism in Asia.

This trailblazing study examines the history of narcotics in Japan to explain the development of global criteria for political legitimacy in nations and empires in the nineteenth and twentieth centuries. Japan underwent three distinct crises of sovereignty in its modern history: in the 1890s, during the interwar period, and in the 1950s. Each crisis provoked successively escalating crusades against opium and other drugs, in which moral entrepreneurs--bureaucrats, cultural producers, merchants, law enforcement, scientists, and doctors, among others--focused on drug use as a means of distinguishing between populations fit and unfit for self-rule. Moral Nation traces the instrumental role of ideologies about narcotics in the country's efforts to reestablish its legitimacy as a nation and empire. As Kingsberg demonstrates, Japan's growing status as an Asian power and a "moral nation" expanded the notion of "civilization" from an exclusively Western value to a universal one. Scholars and students of Japanese history, Asian studies, world history, and global studies will gain an in-depth understanding of how Japan's experience with narcotics influenced global standards for sovereignty and shifted the aim of nation building, making it no longer a strictly political activity but also a moral obligation to society.

Charts the rise of consumerism and the new cosmopolitan material cultures that took shape across the globe from 1500 to 1820.

Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.

In A Medicated Empire, Timothy M. Yang explores the history of Japan's pharmaceutical industry in the early twentieth century through a close account of Hoshi Pharmaceuticals, one of East Asia's most influential drug companies from the late 1910s through the early 1950s. Focusing on Hoshi's connections to Japan's emerging nation-state and empire, and on the ways in which it embraced an ideology of modern medicine as a humanitarian endeavor for greater social good, Yang shows how the industry promoted a hygienic, middle-class culture that was part of Japan's national development and imperial expansion. Yang makes clear that the company's fortunes had less to do with scientific breakthroughs and medical innovations than with Japan's web of social, political, and economic relations. He lays bare Hoshi's business strategies and its connections with politicians and bureaucrats, and he describes how public health authorities dismissed many of its products as placebos at best and poisons at worst. Hoshi, like other pharmaceutical companies of the time, depended on resources and markets opened up, often violently, through colonization. Combining global histories of business, medicine, and imperialism, A Medicated Empire shows how the development of the pharmaceutical industry simultaneously supported and subverted regimes of public health at home and abroad.